IgE and D‐dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria
暂无分享,去创建一个
G. Casazza | S. Ferrucci | G. Genovese | A. Marzano | R. Asero | M. Cugno
[1] M. Maurer,et al. The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change , 2018, Allergy.
[2] M. Maurer,et al. Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria. , 2017, The Journal of allergy and clinical immunology.
[3] S. Ferrucci,et al. Elevated baseline D-dimer plasma levels are associated with a prompt response to omalizumab in patients with severe CSU. , 2017, Journal of Allergy and Clinical Immunology: In Practice.
[4] S. Ferrucci,et al. D-Dimer Plasma Levels Parallel the Clinical Response to Omalizumab in Patients with Severe Chronic Spontaneous Urticaria , 2017, International Archives of Allergy and Immunology.
[5] M. Maurer,et al. Potential blood biomarkers in chronic spontaneous urticaria , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[6] R. Asero,et al. Chronic urticaria and coagulation: pathophysiological and clinical aspects , 2014, Allergy.